Should fee-for-service be for all guideline-advocated acute coronary syndrome (ACS) care? Observations from the Snapshot ACS study.

Conclusion Fee-for-service reimbursement may explain differences in the provision of selected guideline-advocated components of ACS care between privately insured and public patients. What is known about this topic? There is variation in the pattern of acute coronary syndrome care across Australia. What does this paper add? Clear differences in the provision of selected proven therapies for acute coronary syndrome apply independent of whether a fee is charged or not. What are the implications for practitioners? Consideration should be given to the remuneration for proven therapies for acute coronary syndrome care in preference to those not supported by the evidence base. PMID: 25913297 [PubMed - as supplied by publisher]
Source: Australian Health Review - Category: Hospital Management Authors: Tags: Aust Health Rev Source Type: research